Free Trial

RxSight (RXST) Earnings Date, Estimates & Call Transcripts

RxSight logo
$14.95 +0.22 (+1.49%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$15.68 +0.73 (+4.88%)
As of 04/25/2025 05:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RxSight Earnings Summary

Upcoming
Earnings Date
May. 7Before Market OpensEstimated
Consensus EPS
(Feb. 25)
$0.10
Actual EPS
(Feb. 25)
-$0.15 Missed By -$0.25
Actual Revenue
(Feb. 25)
$40.21M

RxSight issued Q4 2024 earnings on February 25, 2025, reporting an EPS of -$0.15, which missed analysts' consensus estimates of $0.10 by $0.25. Quarterly revenue was reported to be $40.21 million, below analyst estimates of $40.23 million. With a trailing EPS of -$0.72, RxSight's earnings are expected to grow next year, from ($0.70) to ($0.39) per share.

Q4 2024 Earnings Resources

RXST Upcoming Earnings

RxSight's next earnings date is estimated for Wednesday, May 7, 2025, based on past reporting schedules.

Get RxSight Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on RxSight and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

RXST Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RXST Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

RxSight Analyst EPS Estimates

Current Year EPS Consensus Estimate
($0.70) EPS
Next Year EPS Consensus Estimate
($0.39) EPS

RxSight Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/7/2025
(Estimated)
--------
2/25/2025Q4 2024$0.10-$0.15 -$0.25-$0.15$40.23M$40.21M
11/7/2024Q3 2024$0.0170-$0.16 -$0.1770-$0.16$35.15M$35.31M
8/5/2024Q2 2024-$0.22-$0.16+$0.06-$0.16$32.33M$34.89M
5/6/2024Q1 2024-$0.1680-$0.25 -$0.0820-$0.25$27.56M$29.51M
2/28/2024Q4 2023-$0.36-$0.26+$0.10-$0.26$28.60M$28.58M
11/9/2023Q3 2023-$0.42-$0.35+$0.07-$0.35$20.81M$22.20M
8/7/2023Q2 2023-$0.47-$0.40+$0.07-$0.40$19.21M$20.81M
5/9/2023Q1 2023-$0.52-$0.42+$0.10-$0.42$16.32M$17.49M

RxSight Earnings - Frequently Asked Questions

RxSight has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 7th, 2025 based off last year's report dates. Learn more on RXST's earnings history.

RxSight updated its FY 2025 earnings guidance on Wednesday, April, 23rd. The company issued revenue guidance of $160.0 million-$175.0 million, compared to the consensus revenue estimate of $190.2 million.

In the previous quarter, RxSight (NASDAQ:RXST) missed the analysts' consensus estimate of $0.10 by $0.25 with a reported earnings per share (EPS) of ($0.15). Learn more on analysts' earnings estimate vs. RXST's actual earnings.

The conference call for RxSight's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for RxSight's latest earnings report can be read online.
Read Transcript

RxSight (NASDAQ:RXST) has a recorded annual revenue of $139.93 million.

RxSight (NASDAQ:RXST) has a recorded net income of -$48.61 million. RXST has generated -$0.72 earnings per share over the last four quarters.

RxSight's earnings are expected to grow from ($0.70) per share to ($0.39) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:RXST) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners